PT958821E - Emulsao gorda que contem um derivado da xantina - Google Patents
Emulsao gorda que contem um derivado da xantinaInfo
- Publication number
- PT958821E PT958821E PT97934737T PT97934737T PT958821E PT 958821 E PT958821 E PT 958821E PT 97934737 T PT97934737 T PT 97934737T PT 97934737 T PT97934737 T PT 97934737T PT 958821 E PT958821 E PT 958821E
- Authority
- PT
- Portugal
- Prior art keywords
- xantin
- derived
- emulsion containing
- fatty emulsion
- hydroxyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Colloid Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Edible Oils And Fats (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22439996 | 1996-08-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT958821E true PT958821E (pt) | 2005-02-28 |
Family
ID=16813150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT97934737T PT958821E (pt) | 1996-08-07 | 1997-08-07 | Emulsao gorda que contem um derivado da xantina |
Country Status (15)
Country | Link |
---|---|
US (1) | US6210687B1 (pt) |
EP (1) | EP0958821B1 (pt) |
JP (2) | JP4179631B2 (pt) |
KR (1) | KR20000029672A (pt) |
CN (1) | CN1227490A (pt) |
AT (1) | ATE281835T1 (pt) |
AU (1) | AU3784597A (pt) |
CA (1) | CA2262578A1 (pt) |
DE (1) | DE69731556T2 (pt) |
DK (1) | DK0958821T3 (pt) |
ES (1) | ES2232877T3 (pt) |
NZ (1) | NZ334299A (pt) |
PT (1) | PT958821E (pt) |
SI (1) | SI0958821T1 (pt) |
WO (1) | WO1998005334A1 (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020123538A1 (en) * | 2000-12-29 | 2002-09-05 | Peiguang Zhou | Hot-melt adhesive based on blend of amorphous and crystalline polymers for multilayer bonding |
US20040229901A1 (en) * | 2003-02-24 | 2004-11-18 | Lauren Otsuki | Method of treatment of disease using an adenosine A1 receptor antagonist |
WO2004096228A1 (en) * | 2003-04-25 | 2004-11-11 | Novacardia, Inc. | Method of improved diuresis in individuals with impaired renal function |
US20060293312A1 (en) * | 2003-04-25 | 2006-12-28 | Howard Dittrich | Method of improved diuresis in individuals with impaired renal function |
EP1932529A1 (en) | 2003-04-25 | 2008-06-18 | Novacardia, Inc. | Method of improved diuresis in individuals with impaired renal function |
WO2005105083A1 (en) * | 2004-04-16 | 2005-11-10 | Novacardia, Inc. | Combination therapy comprising an adenosine a1 receptor antagonist and an aldosterone inhibitor |
CA2608111A1 (en) * | 2005-04-22 | 2006-11-02 | Novacardia, Inc. | Production of emulsions for intravenous injection of water-insoluble pharmaceutical compositions |
US7893070B2 (en) | 2005-08-15 | 2011-02-22 | Provimi Holding B.V. | Method of treating parturient placental mammals in order to reduce maternal and/or uterine exhaustion |
EP1915156B1 (en) * | 2005-08-15 | 2012-07-11 | Provimi Holding B.V. | Use of psychomotor stimulants and compositions containing them in a method of treating parturient placental mammals in order to reduce maternal and/or uterine exhaustion |
EP1961422A1 (en) * | 2005-12-14 | 2008-08-27 | Kyowa Hakko Kogyo Co., Ltd. | Easily absorbed oral preparation containing xanthine derivative |
JP2009532479A (ja) * | 2006-04-06 | 2009-09-10 | ノヴァカーディア,インク. | アデノシンa1受容体アンタゴニストと抗痙攣薬の同時投与 |
WO2007149366A1 (en) * | 2006-06-16 | 2007-12-27 | Novacardia, Inc. | Prolonged improvement of renal function comprising infrequent administration of an aa1ra |
US20080242684A1 (en) * | 2007-03-29 | 2008-10-02 | Howard Dittrich | Methods of administration of adenosine a1 receptor antagonists |
WO2008121893A1 (en) * | 2007-03-29 | 2008-10-09 | Novacardia, Inc. | Methods of treating heart failure and renal dysfunction in individuals with an adenosine a1 receptor antagonist |
HUE026295T2 (en) | 2010-10-12 | 2016-06-28 | The Medicines Co | Clevidipine emulsion formulations containing antimicrobial agents |
US8658676B2 (en) | 2010-10-12 | 2014-02-25 | The Medicines Company | Clevidipine emulsion formulations containing antimicrobial agents |
JP7331417B2 (ja) | 2019-03-29 | 2023-08-23 | セイコーエプソン株式会社 | メディア支持構造及び記録装置 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4146621A (en) * | 1973-01-16 | 1979-03-27 | The Regents Of The University Of Michigan | Process of treating proliferative skin diseases |
JPH0647533B2 (ja) * | 1984-08-10 | 1994-06-22 | 裕 水島 | 4−ビフエニリル酢酸系化合物含有脂肪乳剤 |
ES2039219T3 (es) | 1986-08-11 | 1993-09-16 | American Cyanamid Company | Composiciones para administracion parenteral y su uso. |
JPH0559056A (ja) | 1991-02-25 | 1993-03-09 | Kyowa Hakko Kogyo Co Ltd | キサンチン誘導体 |
CA2093403C (en) * | 1992-04-08 | 1999-08-10 | Fumio Suzuki | Therapeutic agent for parkinson's disease |
WO1994016702A1 (en) * | 1993-01-26 | 1994-08-04 | Kyowa Hakko Kogyo Co., Ltd. | Remedy for irregular bowel movement |
JP3729874B2 (ja) * | 1993-04-07 | 2005-12-21 | 協和醗酵工業株式会社 | キサンチン誘導体 |
US5395836A (en) * | 1993-04-07 | 1995-03-07 | Kyowa Hakko Kogyo Co., Ltd. | 8-tricycloalkyl xanthine derivatives |
JPH07285863A (ja) * | 1994-02-25 | 1995-10-31 | Takeda Chem Ind Ltd | 注射剤組成物およびその製造方法 |
JPH0881360A (ja) * | 1994-07-13 | 1996-03-26 | Wakamoto Pharmaceut Co Ltd | 安定な脂肪乳剤 |
JP4008965B2 (ja) * | 1994-07-29 | 2007-11-14 | 昭和産業株式会社 | レシチン含有脂肪乳剤の調製法 |
JPH08104620A (ja) * | 1994-10-05 | 1996-04-23 | Green Cross Corp:The | 薬物含有脂肪乳剤 |
-
1997
- 1997-08-07 WO PCT/JP1997/002773 patent/WO1998005334A1/ja active IP Right Grant
- 1997-08-07 DE DE69731556T patent/DE69731556T2/de not_active Expired - Lifetime
- 1997-08-07 ES ES97934737T patent/ES2232877T3/es not_active Expired - Lifetime
- 1997-08-07 CN CN97197092A patent/CN1227490A/zh not_active Withdrawn
- 1997-08-07 US US09/230,984 patent/US6210687B1/en not_active Expired - Fee Related
- 1997-08-07 DK DK97934737T patent/DK0958821T3/da active
- 1997-08-07 AU AU37845/97A patent/AU3784597A/en not_active Abandoned
- 1997-08-07 NZ NZ334299A patent/NZ334299A/xx unknown
- 1997-08-07 JP JP50782298A patent/JP4179631B2/ja not_active Expired - Fee Related
- 1997-08-07 KR KR1019997000750A patent/KR20000029672A/ko not_active Application Discontinuation
- 1997-08-07 AT AT97934737T patent/ATE281835T1/de not_active IP Right Cessation
- 1997-08-07 EP EP97934737A patent/EP0958821B1/en not_active Expired - Lifetime
- 1997-08-07 CA CA002262578A patent/CA2262578A1/en not_active Abandoned
- 1997-08-07 PT PT97934737T patent/PT958821E/pt unknown
- 1997-08-07 SI SI9730675T patent/SI0958821T1/xx unknown
-
2008
- 2008-05-27 JP JP2008137775A patent/JP2008231117A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2232877T3 (es) | 2005-06-01 |
JP2008231117A (ja) | 2008-10-02 |
SI0958821T1 (en) | 2005-02-28 |
AU3784597A (en) | 1998-02-25 |
DE69731556T2 (de) | 2005-10-27 |
EP0958821A1 (en) | 1999-11-24 |
KR20000029672A (ko) | 2000-05-25 |
JP4179631B2 (ja) | 2008-11-12 |
EP0958821A4 (en) | 2003-05-02 |
WO1998005334A1 (en) | 1998-02-12 |
CA2262578A1 (en) | 1998-02-12 |
DE69731556D1 (de) | 2004-12-16 |
EP0958821B1 (en) | 2004-11-10 |
CN1227490A (zh) | 1999-09-01 |
DK0958821T3 (da) | 2005-01-03 |
ATE281835T1 (de) | 2004-11-15 |
US6210687B1 (en) | 2001-04-03 |
NZ334299A (en) | 1999-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT958821E (pt) | Emulsao gorda que contem um derivado da xantina | |
PT705833E (pt) | Derivado de dc-89 | |
ES2073889T3 (es) | Composicion despigmentante que contiene unos derivados de arbutosido. | |
ES2176204T3 (es) | Antidepresivos que contienen un derivado de xantina. | |
FI914187A (fi) | Menetelmä valmistaa kaavan /I/ mukaista 1-metyylikarbapeneemijohdosta | |
PT947504E (pt) | Derivados de vitamina d 16-eno | |
SE8502073D0 (sv) | Delta?722-1,2,4-triazolin-5-on-derivat och herbicida kompositioner, som innehaller desamma | |
DE69518410D1 (de) | 22-thiavitamin-d3-derivate | |
KR960700245A (ko) | 메토트렉세이트 유도체[methotrexate derivative] | |
KR880012219A (ko) | p-히드록시 시남아미드 유도체 및 이를 함유한 멜라닌 억제제 | |
KR890008151A (ko) | 키놀린 카르복산의 유도체 | |
KR890009887A (ko) | 이미다졸 유도체 | |
KR890005076A (ko) | 티아디아진 유도체, 그의 제조방법 및 그 화합물을 함유하는 살충제 | |
KR890009876A (ko) | 9-아실아미노- 테트라히드로아크리딘 유도체 및 그 유도체를 활성성분으로 포함하는 기억력 촉진제 | |
KR890005110A (ko) | 신규의 3-아로일-6,7-디히드로-5h-피롤로[1,2-c]이미다졸-7-카르복시산유도체 | |
KR860008184A (ko) | 디옥솔로벤조이소옥사졸 유도체의 제법 | |
KR930000526A (ko) | 피라졸 인산에스테르 유도체 | |
KR860007876A (ko) | 제초제 조성물 | |
CA2264372A1 (fr) | Nouveaux composes du benzocyclobutane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
ES2078337T3 (es) | Derivado de sulfonamida y composicion farmaceutica que lo contiene. | |
ES2042683T3 (es) | Composiciones aromaticas conteniendo un derivado de anisol halogenado. | |
KR960016720A (ko) | 안정화된 3-이소티아졸론 용액 | |
KR880001578A (ko) | 안식향산 유도체 | |
PT1100804E (pt) | Polioxaalcanocarboxilatos de estanho e composicoes que os contem | |
DE69615814T2 (de) | Uch-15-verbindungen |